Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03318562
Title A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Effector Therapeutics
Indications

hepatocellular carcinoma

triple-receptor negative breast cancer

Therapies

Tomivosertib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.